Keyphrases
Indonesia
100%
COVID-19
63%
Virus
56%
Avian Influenza
53%
Acute Respiratory Distress Syndrome
40%
Mesenchymal Stem Cells
40%
Influenza A
35%
Community-acquired Pneumonia
35%
Prostaglandin E2
35%
High Prevalence
35%
Influenza A/H5N1 Virus
30%
Pulmonary Tuberculosis
29%
A(H5N1)
29%
Surabaya
28%
NF-B
27%
Signaling Pathway
26%
Influenza Virus
26%
H5N1 Virus
26%
Highly Pathogenic Avian Influenza Viruses (HPAIV)
25%
Interleukin-1β
24%
COVID-19 Patients
24%
Immunomodulatory Properties
22%
Poultry
22%
Balb C Mice
21%
Lung
21%
Human Influenza
20%
Lung Damage
19%
Severe Group
19%
Pulmonology
19%
Pneumonia Severity Index
17%
Hemagglutinin Cleavage
17%
H3N2 Influenza
17%
Pleuropulmonary
17%
Natural Killer T
17%
Liver Abscess
17%
Yoga
17%
Amoebic Liver Abscess
17%
SRAGE
17%
Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
17%
Forced Expiratory Volume in 1 Second (FEV1)
17%
6-minute Walk Distance (6MWD)
17%
VATS Resection
17%
Bleb
17%
Krebs Von Den Lungen-6 (KL-6)
17%
Wedge Resection
17%
Primary Spontaneous Pneumothorax
17%
Virological Surveillance
17%
Nontuberculous
17%
Tuberculosis Pleural Effusion
17%
Immunoregulation
17%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
42%
Influenza A Virus (H5N1)
38%
Adult Respiratory Distress Syndrome
35%
Cross-Sectional Study
35%
Coronavirinae
35%
Tumor Necrosis Factor
35%
Avian Influenza (H5N1)
29%
Prevalence
29%
Highly Pathogenic Avian Influenza
23%
Cytokine
20%
Lung Injury
19%
Infection
18%
Interleukin 10
17%
Severe Acute Respiratory Syndrome
17%
Asymptomatic Infection
17%
Interleukin 1
17%
Advanced Glycation End Product Receptor
17%
Chronic Obstructive Lung Disease
17%
Acute Lung Injury
17%
Aspergilloma
17%
Avian Influenza
17%
Seasonal Influenza
17%
Influenza
17%
Pleura Effusion
17%
Quinolone Derivative
17%
Recurrent Disease
17%
Pneumonia
17%
Bagg Albino Mouse
17%
Community Acquired Pneumonia
17%
Hemoptysis
17%
Aves
17%
Virus Infection
16%
Biological Marker
14%
Antivirus Agent
13%
Mortality Rate
13%
Influenza Virus
11%
Lung Tuberculosis
11%
Cytokine Storm
8%
Randomized Clinical Trial
8%
Pandemic
8%
Interleukin 6
8%
Disease Severity
7%
Anti-Inflammatory Drug
6%
Medical History
5%
Influenza A Virus
5%
Seroprevalence
5%
Avian Influenza Virus
5%
2009 H1N1 Influenza
5%
Respiratory Tract Disease
5%
Treatment Group
5%
Immunology and Microbiology
Virus
81%
Influenza A Virus (H5N1)
80%
Influenza
57%
Aves
42%
Prevalence
26%
Hemagglutinin
23%
Avian Influenza Virus
21%
Bagg Albino Mouse
21%
Proinflammatory Cytokine
19%
Innate Immune System
17%
Sputum
17%
Acid Fast Bacterium
17%
Pulmonary Inflammation
17%
Secretion (Process)
17%
Sparrow
17%
Antiinflammatory Activity
17%
Chemokine
17%
Pathogen Load
17%
Interleukin 6
17%
T Cell
17%
COVID-19
17%
Natural Killer Cell
17%
Bone Marrow Derived Mesenchymal Stem Cell
17%
Mesenchymal Stem Cell
17%
Hemagglutination
17%
Highly Pathogenic Avian Influenza Virus
17%
Influenza A Virus (H3N2)
17%
CD4
13%
CD8
13%
Body Weight
12%
Hemagglutination Inhibition
10%
CD3 Antigen
9%
Viral Disease
9%
Influenza Virus
8%
Tyrosine
8%
Cladistics
7%
Mouse Model
6%
Migrant Bird
5%
Mycobacterium Tuberculosis
5%
Virogenesis
5%
Tumor Necrosis Factor
5%
Interleukin-1
5%
